CCL3 serves as a potential plasma biomarker in knee degeneration (osteoarthritis)

Osteoarthritis and Cartilage

Volumn 23, Issue 8, 2015, Pages 1405-1411

  Zhao, X Y ^a   Yang, Z B ^a   Zhang, Z J ^a   Zhang, Z Q ^a   Kang, Y ^a   Huang, G X ^a   Wang, S W ^a   Huang, H ^a   Liao, W M ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarker; Chemokines; Knee degeneration (osteoarthritis); Plasma

Indexed keywords

CXCL1 CHEMOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CCL3 PROTEIN, HUMAN; CCL4 PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE ARTHROSCOPY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL3; CHEMOKINE CCL4; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREDICTIVE VALUE OF TESTS; RESISTIN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84938482969     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.04.002     Document Type: Article

References (36)

1. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013, 380(9859):2163-2196.
2. Kadam U.T., Jordan K., Croft P.R. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 2004, 63(4):408-414.
3. Nüesch E., Dieppe P., Reichenbach S., Williams S., Iff S., Jüni P. All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ 2011, 342:d1165.
4. Hochberg M.C. Mortality in osteoarthritis. Clin Exp Rheumatol 2008, 26(5):S120.
5. Bijlsma J.W.J., Berenbaum F., Lafeber F.P.J.G. Osteoarthritis: an update with relevance for clinical practice. Lancet 2011, 377(9783):2115-2126.
6. Kraus V.B., Nevitt M., Sandell L.J. Summary of the OA biomarkers workshop 2009 biochemical biomarkers: biology, validation, and clinical studies. Osteoarthritis Cartilage 2010, 18(6):742-745.
7. Wakitani S., Nawata M., Kawaguchi A., Okabe T., Takaoka K., Tsuchiya T., et al. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology 2007, 46(11):1652-1656.
8. Šenolt L., Braun M., Olejarova M., Forejtová S., Gatterová J., Pavelka K. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein. Ann Rheum Dis 2005, 64(6):886-890.
9. Hoch J.M., Mattacola C.G., Medina McKeon J.M., Howard J.S., Lattermann C. Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 2011, 19(12):1396-1404.
10. Gerard C., Rollins B.J. Chemokines and disease. Nat Immunol 2001, 2(2):108-115.
11. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol 2011, 23(5):471.
12. Haringman J.J., Ludikhuize J., Tak P.P. Chemokines in joint disease: the key to inflammation?. Ann Rheum Dis 2004, 63(10):1186-1194.
13. Sandell L.J., Xing X., Franz C., Davies S., Chang L.W., Patra D. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL1β. Osteoarthritis Cartilage 2008, 16(12):1560-1571.
14. Zhang Z., Xing X., Hensley G., Chang L.W., Liao W., Abu-Amer Y., et al. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 2010, 62(7):1993-2003.
15. Kapoor M., Martel-Pelletier J., Lajeunesse D., Pelletier J.P., Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2010, 7(1):33-42.
16. Lee J.H., Ort T., Ma K., Picha K., Carton J., Marsters P.A., et al. Resistin is elevated following traumatic joint injury and causes matrix degradation and release of inflammatory cytokines from articular cartilage invitro. Osteoarthritis Cartilage 2009, 17(5):613-620.
17. Altman R.D., Gold G.E. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage 2007, 15:1-56.
18. Luyten F.P., Denti M., Filardo G., Kon E., Engebretsen L. Definition and classification of early osteoarthritis of the knee. Knee Surg Sports Traumatol Arthrosc 2012, 20(3):401-406.
19. Ray C.A., Bowsher R.R., Smith W.C., Devanarayan V., Willey M.B., Brandt J.T., et al. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. JPharm Biomed Anal 2005, 36(5):1037-1044.
20. DuPont N.C., Wang K., Wadhwa P.D., Culhane J.F., Nelson E.L. Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. JReprod Immunol 2005, 66(2):175-191.
21. Endo H., Akahoshi T., Takagishi K., Kashiwazaki S., Matsushima K. Elevation of interleukin-8 (IL-8) levels in joint fluids of patients with rheumatoid arthritis and the induction by IL-8 of leukocyte infiltration and synovitis in rabbit joints. Lymphokine Cytokine Res 1991, 10:245-252.
22. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. JImmunol 2005, 174(9):5789-5795.
23. Koch A.E., Kunkel S.L., Shah M.R., Piccardi N., Guillou G.B., Msika P., et al. Macrophage inflammatory protein-1β: a CC chemokine in osteoarthritis. Clin Immunol Immunopathol 1995, 77(3):307-314.
24. Maurer M., Von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004, 36(10):1882-1886.
25. Wang J., Tian Y., Phillips K.L.E., Chiverton N., Haddock G., Bunning R.A., et al. Tumor necrosis factor α-and interleukin-1β dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Arthritis Rheum 2013, 65(3):832-842.
26. Koch A.E., Kunkel S.L., Harlow L.A., Mazarakis D.D., Haines G.K., Burdick M.D., et al. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. JClin Investig 1994, 93(3):921.
27. Dapunt U., Maurer S., Giese T., Gaida M.M., Hänsch G.M. The macrophage inflammatory proteins MIP1α (CCL3) and MIP2α (CXCL2) in implant-associated osteomyelitis: linking inflammation to bone degradation. Mediat Inflamm 2014, 2014:728619.
28. Chintalacharuvu S.R., Wang J.X., Giaconia J.M., Venkataraman C. An essential role for CCL3 in the development of collagen antibody-induced arthritis. Immunol Lett 2005, 100(2):202-204.
29. Toh K., Kukita T., Wu Z., Kukita A., Sandra F., Tang Q.Y., et al. Possible involvement of MIP-1α in the recruitment of osteoclast progenitors to the distal tibia in rats with adjuvant-induced arthritis. Lab Investig 2004, 84(9):1092-1102.
30. Vallet S., Pozzi S., Patel K., Vaghela N., Fulciniti M.T., Veiby P., et al. Anovel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function. Leukemia 2011, 25(7):1174-1181.
31. Huebner J.L., Kraus V.B. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2006, 14(9):923-930.
32. Vangsness C.T., Burke W.S., Narvy S.J., MacPhee R.D., Fedenko A.N. Human knee synovial fluid cytokines correlated with grade of knee osteoarthritis. Bull NYU Hosp Jt Dis 2011, 69(2):122-127.
33. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000, 1(6):510-514.
34. Kloesch B., Liszt M., Steiner G., Bröll J. Inhibitors of p38 and ERK1/2 MAPkinase and hydrogen sulphide block constitutive and IL-1β-induced IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Rheumatol Int 2012, 32(3):729-736.
35. Zhang Z., Bryan J.L., DeLassus E., Chang L.W., Liao W., Sandell L.J. CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β. JBiol Chem 2010, 285(43):33092-33103.
36. Zhang Z., Zhang Z., Kang Y., Hou C., Duan X., Sheng P., et al. Resistin stimulates expression of chemokine genes in chondrocytes via combinatorial regulation of C/EBPβ and NF-κB. Int J Mol Sci 2014, 15(10):17242-17255.